Immunic, Inc.
IMUX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001280776
No open-market purchases or sales by Immunic, Inc. insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $130.6M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Immunic, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 67 | 2 | 62 | −3 |
| Shares | 17.4M | 38.8K | 24.4M | +6.95M (+40.0%) |
| Value | $55.1M | $122.5K | $34.0M | −$20.9M (−38.1%) |
2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (18)
Institutions that held Immunic, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BVF Inc | 1,149,425 | $1.61M | 0.07% |
| Anson Funds Management LP | 664,935 | $930.9K | 0.30% |
| Ikarian Capital, LLC | 650,000 | $910.0K | 0.38% |
| Great Point Partners LLC | 632,184 | $885.1K | 0.18% |
| Ra Capital Management, L.P. | 632,184 | $885.1K | 0.02% |
| Vivo Capital, LLC | 632,184 | $833.0K | 0.10% |
| AWH Capital, L.P. | 500,000 | $700.0K | 0.87% |
| Silverarc Capital Management, LLC | 350,656 | $490.9K | 0.17% |
| Jefferies Financial Group Inc. | 342,410 | $479.4K | 0.01% |
| Adage Capital Partners GP, L.L.C. | 309,770 | $433.7K | 0.00% |
| Boothbay Fund Management, LLC | 117,130 | $164.0K | 0.01% |
| Barclays PLC | 79,368 | $111.1K | 0.00% |
| Jane Street Group, LLC | 71,503 | $100.1K | 0.00% |
| Prudential Financial Inc | 27,250 | $38.1K | 0.00% |
| Citadel Advisors LLC | 25,204 | $35.3K | 0.00% |
| Two Sigma Securities, LLC | 25,030 | $35.0K | 0.00% |
| Kingsview Wealth Management, LLC | 10,000 | $14.0K | 0.00% |
| Advisor Group Holdings, Inc. | 72 | $87 | 0.00% |
Sold out (21)
Institutions that held Immunic, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Lynx1 Capital Management LP | 1,072,288 | $3.39M |
| Janus Henderson Group PLC | 314,382 | $990.0K |
| Soleus Capital Management, L.P. | 240,000 | $758.0K |
| UBS Oconnor LLC | 197,988 | $626.0K |
| Renaissance Technologies LLC | 130,665 | $413.0K |
| Schonfeld Strategic Advisors LLC | 104,400 | $330.0K |
| Walleye Capital LLC | 104,150 | $329.0K |
| D. E. Shaw & Co., Inc. | 56,977 | $180.0K |
| Parallax Volatility Advisers, L.P. | 50,715 | $160.0K |
| Engineers Gate Manager LP | 30,444 | $96.0K |
| Jacobs Levy Equity Management, Inc | 25,421 | $80.0K |
| J. Goldman & Co LP | 23,583 | $75.0K |
| Susquehanna Fundamental Investments, LLC | 17,673 | $56.0K |
| Goldman Sachs Group Inc | 14,263 | $45.0K |
| Qube Research & Technologies Ltd | 14,342 | $45.0K |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 3,031 | $10.0K |
| Baldwin Brothers Inc | 1,000 | $3.00K |
| Citigroup Inc | 326 | $1.00K |
| Institutional & Family Asset Management, LLC | 297 | $1.00K |
| China Universal Asset Management Co., Ltd. | 287 | $1.00K |
| Daiwa Securities Group Inc. | 39 | $0 |
Not filed for Q4 2022 yet (2)
Institutions that held Immunic, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Jefferies Group LLC | 38,703 | $122.3K |
| American Portfolios Advisors | 62 | $196 |